What You Should Know:
- Tempus AI, Inc., a technology company focused on advancing precision medicine with AI, has acquired Paige, an AI company specializing in digital pathology.
- The acquisition, valued at $81.25M, paid predominantly in Tempus common stock, is a strategic move to grow Tempus's dataset, expand its technical team, and strengthen its position in digital pathology.
A Comprehensive Dataset and Pioneering AI Applications
Since its founding in 2017, Paige has
Read More
Digital Pathology
PathAI and Moffitt Cancer Center Partner to Deploy AI Digital Pathology Platform, AISight® Dx
What You Should Know:
- PathAI, a provider of AI and digital pathology solutions, and Moffitt Cancer Center, a top cancer hospital, have announced a multi-year strategic collaboration to deploy PathAI’s digital pathology platform, AISight® Dx, across Moffitt’s pathology programs. The partnership aims to transform cancer detection and research through the use of AI.
AISight® Dx: Cloud-Native Digital Pathology
AISight® Dx is a cloud-native digital pathology image management
Read More
Fujifilm and AWS Partner with Major Health System to Digitize Pathology
What You Should Know:
- FUJIFILM Healthcare Americas Corporation, in collaboration with Amazon Web Services (AWS), has been selected by a leading East Coast health system to implement its Synapse® Pathology solution.
- The initiative aims to transform the health system's pathology delivery and reduce diagnosis timelines through digitalization. The fully cloud-based Synapse Pathology platform will be deployed across five hospital sites, making it a first-of-its-kind,
Read More
M&A: Evident to Acquire Digital Pathology Solution Pramana
What You Should Know:
- Evident, a leader in clinical microscopy and superior optics, today announced a definitive agreement to acquire Pramana, Inc., a manufacturer of digital pathology solutions. Financial details of the acquisition were not disclosed.
- The strategic acquisition brings together Pramana’s cutting-edge autonomous whole slide imaging technologies with Evident’s longstanding expertise to revolutionize the market for digital pathology solutions and usher in what both
Read More
PathAI and Northwestern Medicine to Transform Pathology Diagnostics with AI
What You Should Know:
- PathAI, a provider of AI-powered pathology solutions, and Northwestern Medicine, Chicago’s premier integrated academic health system announced a strategic multi-year collaboration aimed at transforming pathology diagnostics through the power of artificial intelligence (AI).
- The partnership will see Northwestern Medicine implement PathAI’s AISight™ digital pathology image management system with the goal of driving efficiency and quality in its pathology
Read More
Precision for Medicine & PathAI Launch Strategic AI Digital Pathology Partnership
What You Should Know:
- Precision for Medicine, a provider of next-generation drug development research and services, and PathAI, a global leader in digital pathology, announced a strategic collaboration today.
- The partnership aims to jointly develop novel AI-based technologies and integrate PathAI’s advanced digital pathology and analysis capabilities across Precision for Medicine’s comprehensive clinical trial and biospecimen operations.
AI-Powered Clinical Trial Services and
Read More
Endeavor Health Partners with Google Cloud to Develop Cloud-Based Digital Pathology Model
What You Should Know:
- Endeavor Health, a Chicagoland-based integrated health system announced the development of a groundbreaking, fully cloud-based digital pathology platform in collaboration with Google Cloud, establishing a novel model poised to reshape the future of this critical medical field.
- Endeavor Health's pioneering model represents a significant leap forward from previous industry efforts to explore digital pathology. By establishing the first fully connected,
Read More
Proscia Secures $50M to Accelerate AI-Driven Digital Pathology
What You Should Know:
- Proscia, a software company focused on digitizing and applying AI to pathology, has announced a $50M funding round, bringing its total capital raised to $130M.
- The funding, led by Insight Partners, AI Capital Partners, and Triangle Peak Partners, will be used to further expand the adoption of Proscia's platform, integrate more AI capabilities, and leverage strategic OEM partnerships with industry giants like Agilent Technologies and Siemens
Read More
elea Raises $4.3M AI-Powered Pathology Operating System
What You Should Know:
- elea, an innovative AI platform designed to supercharge healthcare professionals' ability to deliver life-saving diagnoses and care, has announced a $4.3M (€4M)funding round led by Fly Ventures and Giant Ventures.
- The company has also secured a milestone partnership with one of Germany's largest and most critical Medizinische Versorgungszentrum (MVZ) hospital groups.
Addressing the Healthcare Crisis with AI
elea was founded to address the growing
Read More
Stemline Therapeutics to Deploy Tempus Next’s AI-Enabled Care Pathway Intelligence Platform
What You Should Know:
- Tempus, a provider of AI-driven precision medicine, and Stemline Therapeutics, Inc. ("Stemline"), a wholly-owned subsidiary of the Menarini Group announced a new collaboration to improve the use of ESR1 testing in metastatic breast cancer (mBC).
- The partnership will leverage Tempus' Next platform, an AI-enabled care pathway intelligence tool, to help clinicians determine when ESR1 testing may be appropriate for their patients.
Challenges in ESR1
Read More
